The relative cost-effectiveness of proton-pump inhibitors (PPIs) in the maintenance therapy of erosive reflux esophagitis was studied. Decision analysis was used to model the cost-effectiveness of ...

The seven available PPI medicines are roughly equal in effectiveness and safety but differ in cost. Three—omeprazole (Prilosec, Prilosec OTC), lansoprazole (Prevacid, Prevacid 24HR), and ...

“PPI use does not appear to be associated with osteoporosis or accelerated [bone mineral density (BMD)] loss,” according to Laura Targownik and colleagues from the University of Manitoba ...

Otherwise, oral and IV proton pump inhibitors work similarly in the body and have comparable effectiveness. Oral PPIs are the more common form because they are easier to administer and more cost ...

Over 11 years, women ages 65-plus who were continuously taking PPIs were significantly more likely to develop CVD (cardiovascular disease) than those not taking the meds -- and the more PPI doses ...

This cost-effectiveness analysis was constructed to ... rabeprazole, pantoprazole, PPIs, healing, recurrence, and maintenance. Titles, abstracts, and articles were subjected to explicit inclusion ...

Generally speaking, one PPI doesn't differ all that much from others. They all have similar mechanisms of action and similar ...